Ayx Isabelle, Bauer Rouven, Schönberg Stefan O, Hertel Alexander
Department of Radiology and Nuclear Medicine, Heidelberg University Medical Faculty Mannheim, Mannheim, Germany.
Rofo. 2025 Jul;197(7):781-790. doi: 10.1055/a-2499-3122. Epub 2025 Jan 23.
The need for effective early detection and optimal therapy monitoring of cardiovascular diseases as the leading cause of death has led to an adaptation of the guidelines with a focus on cardiac computed tomography (CCTA) in patients with a low to intermediate risk of coronary heart disease (CHD). In particular, the introduction of photon-counting computed tomography (PCCT) in CT diagnostics promises significant advances through higher temporal and spatial resolution, and also enables advanced texture analysis, known as radiomics analysis. Originally developed in oncological imaging, radiomics analysis is increasingly being used in cardiac imaging and research. The aim is to generate imaging biomarkers that improve the early detection of cardiovascular diseases and therapy monitoring.The present study summarizes the current developments in cardiac CT texture analysis with a particular focus on evaluations of PCCT data sets in different regions, including the myocardium, coronary plaques, and pericoronary/epicardial fat tissue.These developments could revolutionize the diagnosis and treatment of cardiovascular diseases and significantly improve patient prognoses worldwide. The aim of this review article is to shed light on the current state of radiomics research in cardiovascular imaging and to identify opportunities for establishing it in clinical routine in the future. · Radiomics: Enables deeper, objective analysis of cardiovascular structures via feature quantification.. · PCCT: Provides a higher quality image, improving stability and reproducibility in cardiac CT.. · Early detection: PCCT and radiomics enhance cardiovascular disease detection and management.. · Challenges: Technical and standardization issues hinder widespread clinical application.. · Future: Advancing PCCT technologies could soon integrate radiomics in routine practice.. · Ayx I, Bauer R, Schönberg SO et al. Cardiac Radiomics Analyses in Times of Photon-counting Computed Tomography for Personalized Risk Stratification in the Present and in the Future. Rofo 2025; DOI 10.1055/a-2499-3122.
作为主要死因的心血管疾病需要有效的早期检测和最佳治疗监测,这导致了相关指南的调整,重点关注冠心病(CHD)低至中度风险患者的心脏计算机断层扫描(CCTA)。特别是,光子计数计算机断层扫描(PCCT)在CT诊断中的引入有望通过更高的时间和空间分辨率取得重大进展,还能实现先进的纹理分析,即放射组学分析。放射组学分析最初是在肿瘤成像中开发的,现在越来越多地用于心脏成像和研究。其目的是生成成像生物标志物,以改善心血管疾病的早期检测和治疗监测。本研究总结了心脏CT纹理分析的当前进展,特别关注对不同区域(包括心肌、冠状动脉斑块和冠状动脉周围/心外膜脂肪组织)的PCCT数据集的评估。这些进展可能会彻底改变心血管疾病的诊断和治疗,并显著改善全球患者的预后。这篇综述文章的目的是阐明心血管成像中放射组学研究的现状,并确定未来将其纳入临床常规的机会。·放射组学:通过特征量化对心血管结构进行更深入、客观的分析。·PCCT:提供更高质量的图像,提高心脏CT的稳定性和可重复性。·早期检测:PCCT和放射组学增强了心血管疾病的检测和管理。·挑战:技术和标准化问题阻碍了其广泛的临床应用。·未来:先进的PCCT技术可能很快将放射组学整合到常规实践中。·艾克斯I、鲍尔R、舍恩贝格SO等。光子计数计算机断层扫描时代的心脏放射组学分析用于当前和未来的个性化风险分层。《德国放射学杂志》2025年;DOI 10.1055/a - 2499 - 3122